Nithiodote is a two-agent cyanide antidote kit that pairs sodium nitrite with sodium thiosulfate. On its official labeling (DailyMed), it is presented for use in acute cyanide poisoning and includes prescribed dosing instructions for sodium thiosulfate (250 mg/kg administered as 1 mL/kg), with a stated maximum total dose of 50 mL. The product targets emergency clinicians, toxicologists, and prehospital teams that follow local protocols for cyanide exposure treatment.
This review synthesizes the Nithiodote prescribing information (package insert / DailyMed) and peer-reviewed efficacy data from Bebarta et al. (2016/2017), which tested sodium nitrite and sodium thiosulfate in three mammalian lethal cyanide models (mice, rabbits, pigs). The Bebarta studies specifically examined intramuscular administration and reported that the two agents were effective when given IM in those controlled models. Where possible, statements here cite those label and study-derived specifics.
High-level verdict: Nithiodote provides the established dual-agent approach (nitrite + thiosulfate) documented on the official label and supported by animal-model evidence for intramuscular efficacy. Its strengths are a clearly defined weight-based thiosulfate dose (250 mg/kg = 1 mL/kg, max 50 mL) and reproducible effect in lethal models. Major limitations are that US labeling describes intravenous administration (which complicates out-of-hospital use), important boxed warnings are present on the label, and the IM effectiveness data come from animal studies rather than large human trials.
Does Nithiodote neutralize cyanide effectively?
Peer-reviewed work by Bebarta et al. (2016/2017) tested sodium nitrite and sodium thiosulfate in three mammalian lethal cyanide models — mice (cyanide gas inhalation, postexposure treatment), rabbits (IV sodium cyanide infusion with hypotension-triggered treatment), and pigs (IV potassium cyanide infusion with apnea-triggered treatment) — and concluded that the two agents administered intramuscularly were effective against severe cyanide poisoning in these models.
The clinical label for Nithiodote documents the two-agent approach for cyanide poisoning; however, the strongest direct human-evidence for intramuscular administration is lacking in the cited studies, which were controlled animal experiments. The Bebarta results support IM as a potential route when IV is impractical, but clinicians should weigh the animal-model basis against local protocols and regulatory labeling.
What are the labeled doses and practical administration notes?
The prescribing information and available package documentation list sodium thiosulfate dosing as 250 mg/kg, presented as 1 mL/kg of the product, with a maximum total dose not to exceed 50 mL; this is a weight-based regimen that requires calculation in an emergency. The study abstract and label excerpts also note that historically, US antidotes are expected to be administered intravenously.
Bebarta’s animal studies specifically evaluated intramuscular injections of sodium nitrite and sodium thiosulfate and found them effective in mice, rabbits and pigs; that provides evidence that IM dosing can work physiologically, but the label remains an important operational source for approved administration routes and exact preparation/compatibility steps.
Known safety considerations and warnings
The DailyMed label entry cited in the brief lists safety information and boxed warnings sections for Nithiodote; those label elements indicate the presence of important risk information that prescribers must consult before use. The presence of boxed warnings on the official label is a concrete prompt to review adverse effects and contraindications in the full prescribing information.
Because the Bebarta efficacy evidence comes from controlled animal models, human safety profiles (especially for IM vs IV administration) rely on label guidance and clinical judgment. Weight-based dosing and potentially rapid administration in emergencies increase the risk of dosing errors if protocols and checks are not in place.
How practical is Nithiodote in real-world emergency settings?
On-label intravenous administration can be limiting in prehospital mass-casualty or austere settings where IV access is difficult; the Bebarta studies demonstrate that intramuscular injections of sodium nitrite and sodium thiosulfate were effective in animal models, which supports consideration of IM use when IV is not feasible — but this is an extrapolation from animal data to clinical practice.
Operationally, responders must perform weight-based dose calculations under stress (sodium thiosulfate 250 mg/kg = 1 mL/kg, cap at 50 mL), and follow institutional protocols. The product’s utility will depend on training, dosing aids, and local approval for IM versus IV administration.
How does labeling affect use, and what are other antidote options?
The official Nithiodote labeling (DailyMed/prescribing information) provides the authoritative route and dosing instructions and includes boxed warnings and safety sections that must be reviewed prior to use. The Bebarta studies note that the two antidotes for acute cyanide poisoning in the United States have historically been administered by intravenous injection, which is why IM efficacy data are operationally significant.
Clinics and EMS systems should compare institutional protocols and stock other accepted antidotes per their formularies and guidelines, and confirm regulatory/medical oversight if considering intramuscular use based on the animal-model evidence.
Pros & Cons
- ✅ Peer-reviewed animal-model evidence (Bebarta et al. 2016/2017) shows sodium nitrite and sodium thiosulfate administered intramuscularly were effective in lethal cyanide models (mice, rabbits, pigs).
- ✅ Contains the two-agent approach (nitrite + thiosulfate) that targets cyanide biochemistry as described in the prescribing information.
- ✅ Clear weight-based thiosulfate dosing on label: 250 mg/kg expressed as 1 mL/kg, with a maximum total dose of 50 mL, which simplifies calculations once concentration is known.
- ✅ Official prescribing information and label are available (DailyMed), providing authoritative safety and administration details.
- ✅ Provides an evidence-backed option for scenarios where intramuscular administration may be considered when IV access is not practical (based on animal data).
- ❌ Official label in the U.S. context describes intravenous administration, which limits on-label use out of hospital without local protocol adjustments.
- ❌ Safety sections and boxed warnings are present on the DailyMed label, requiring careful review; the brief indicates those warnings exist but does not detail them here.
- ❌ IM efficacy evidence comes from animal studies (mice, rabbits, pigs) rather than large human clinical trials, so extrapolation to humans carries uncertainty.
- ❌ Weight-based dosing (250 mg/kg = 1 mL/kg, max 50 mL) increases the potential for calculation or dosing errors in high-stress emergencies if no aids are available.
How It Compares to the Competition
- Cyanokit (hydroxocobalamin) — Alternative IV antidote used for cyanide poisoning; different active agent (hydroxocobalamin) and typically supplied as an IV product.
- Amyl nitrite (medical inhalant) — Rapid-acting inhalant historically used in some cyanide protocols; route and mechanism differ from the nitrite/thiosulfate kit.
- Generic sodium thiosulfate IV formulations — Single-agent thiosulfate IV preparations are available in formularies and are often used in combination with nitrite strategies per institutional protocols.
Who Should Buy This & Who Should Skip It
Buy it if: Emergency departments, hospital toxicology services, and EMS systems that maintain cyanide antidote stock and have protocols for IV administration should keep Nithiodote available. Systems considering intramuscular use in the field should only do so with medical oversight and protocols referencing the Bebarta animal-model evidence.
Skip it if: Facilities without trained staff for weight-based emergency dosing or without clear protocols for cyanide treatment should not rely solely on Nithiodote; organizations without medical oversight for off-label IM use should consider alternatives authorized for their intended route.
Search Purchase Options
Use these links to search for Nithiodote (sodium nitrite/sodium thiosulfate kit) on trusted marketplaces. The links open in new tabs; if you buy through them, we may earn a commission at no extra cost to you.
* Affiliate links: you pay the same price either way.